TY  - JOUR
AU  - Ferreira, Vitor
AU  - Folgueira, Cintia
AU  - Guillén, Maria
AU  - Zubiaur, Pablo
AU  - Navares, Marcos
AU  - Sarsenbayeva, Assel
AU  - López-Larrubia, Pilar
AU  - Eriksson, Jan W
AU  - Pereira, Maria J
AU  - Abad-Santos, Francisco
AU  - Sabio, Guadalupe
AU  - Rada, Patricia
AU  - Valverde, Ángela M
PY  - 2022
DO  - 10.1016/j.metabol.2022.155335
UR  - http://hdl.handle.net/20.500.12105/15819
AB  - Second-generation antipsychotics (SGAs) are a mainstay therapy for schizophrenia. SGA-treated patients present higher risk for weight gain, dyslipidemia and hyperglycemia. Herein, we evaluated the effects of olanzapine (OLA), widely prescribed SGA, in...
LA  - eng
PB  - Elsevier
KW  - AMP-Activated Protein Kinases
KW  - Hypothalamus
KW  - Male
KW  - Mice
KW  - Animals
KW  - Olanzapine
KW  - Phosphorylation
KW  - Thermogenesis
KW  - Body Weight
KW  - Energy Metabolism
KW  - Weight Gain
KW  - Adipose Tissue, Brown
TI  - Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight.
TY  - journal article
ER  -